648 related articles for article (PubMed ID: 26791086)
1. Interleukin-37 suppresses tumor growth through inhibition of angiogenesis in non-small cell lung cancer.
Ge G; Wang A; Yang J; Chen Y; Yang J; Li Y; Xue Y
J Exp Clin Cancer Res; 2016 Jan; 35():13. PubMed ID: 26791086
[TBL] [Abstract][Full Text] [Related]
2. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-36α suppresses growth of non-small cell lung cancer in vitro by reducing angiogenesis.
Xie X; Hu H; He J; Liu Y; Guo F; Luo F; Jiang M; Wang L
FEBS Open Bio; 2021 May; 11(5):1353-1363. PubMed ID: 33713575
[TBL] [Abstract][Full Text] [Related]
4. Aberrant p53 expression correlates with expression of vascular endothelial growth factor mRNA and interleukin-8 mRNA and neoangiogenesis in non-small-cell lung cancer.
Yuan A; Yu CJ; Luh KT; Kuo SH; Lee YC; Yang PC
J Clin Oncol; 2002 Feb; 20(4):900-10. PubMed ID: 11844810
[TBL] [Abstract][Full Text] [Related]
5. Apelin expression in human non-small cell lung cancer: role in angiogenesis and prognosis.
Berta J; Kenessey I; Dobos J; Tovari J; Klepetko W; Jan Ankersmit H; Hegedus B; Renyi-Vamos F; Varga J; Lorincz Z; Paku S; Ostoros G; Rozsas A; Timar J; Dome B
J Thorac Oncol; 2010 Aug; 5(8):1120-9. PubMed ID: 20581707
[TBL] [Abstract][Full Text] [Related]
6. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
[TBL] [Abstract][Full Text] [Related]
7. FOXD3 suppresses tumor growth and angiogenesis in non-small cell lung cancer.
Yan JH; Zhao CL; Ding LB; Zhou X
Biochem Biophys Res Commun; 2015 Oct; 466(1):111-6. PubMed ID: 26341266
[TBL] [Abstract][Full Text] [Related]
8. NDRG1/Cap43/Drg-1 may predict tumor angiogenesis and poor outcome in patients with lung cancer.
Azuma K; Kawahara A; Hattori S; Taira T; Tsurutani J; Watari K; Shibata T; Murakami Y; Takamori S; Ono M; Izumi H; Kage M; Yanagawa T; Nakagawa K; Hoshino T; Kuwano M
J Thorac Oncol; 2012 May; 7(5):779-89. PubMed ID: 22481237
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis.
Han H; Silverman JF; Santucci TS; Macherey RS; d'Amato TA; Tung MY; Weyant RJ; Landreneau RJ
Ann Surg Oncol; 2001; 8(1):72-9. PubMed ID: 11206229
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-9 promotes tumorigenesis through augmenting angiogenesis in non-small cell lung cancer.
He J; Wang L; Zhang C; Shen W; Zhang Y; Liu T; Hu H; Xie X; Luo F
Int Immunopharmacol; 2019 Oct; 75():105766. PubMed ID: 31352324
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer.
Chen JJ; Yao PL; Yuan A; Hong TM; Shun CT; Kuo ML; Lee YC; Yang PC
Clin Cancer Res; 2003 Feb; 9(2):729-37. PubMed ID: 12576442
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-17 potently increases non-small cell lung cancer growth.
Wei L; Wang H; Yang F; Ding Q; Zhao J
Mol Med Rep; 2016 Feb; 13(2):1673-80. PubMed ID: 26708832
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of S100A13 protein is associated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer.
Miao S; Qiu T; Zhao Y; Wang H; Sun X; Wang Y; Xuan Y; Qin Y; Jiao W
Thorac Cancer; 2018 Sep; 9(9):1136-1144. PubMed ID: 30047626
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-8 in non-small cell lung carcinoma: relation with angiogenic pattern and p53 alterations.
Boldrini L; Gisfredi S; Ursino S; Lucchi M; Mussi A; Basolo F; Pingitore R; Fontanini G
Lung Cancer; 2005 Dec; 50(3):309-17. PubMed ID: 16125276
[TBL] [Abstract][Full Text] [Related]
15. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome.
Zhang L; Chen J; Ke Y; Mansel RE; Jiang WG
Int J Mol Med; 2006 May; 17(5):937-44. PubMed ID: 16596284
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C
J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951
[TBL] [Abstract][Full Text] [Related]
17. Expression of TLR9 in tumor-infiltrating mononuclear cells enhances angiogenesis and is associated with a worse survival in lung cancer.
Belmont L; Rabbe N; Antoine M; Cathelin D; Guignabert C; Kurie J; Cadranel J; Wislez M
Int J Cancer; 2014 Feb; 134(4):765-77. PubMed ID: 23913633
[TBL] [Abstract][Full Text] [Related]
18. [Interleukin 7 and its receptor promote cell proliferation and induce lymphangiogenesis in non-small cell lung cancer].
Ming J; Zhang QF; Jiang YD; Jiang GC; Qiu XS
Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):511-8. PubMed ID: 23157741
[TBL] [Abstract][Full Text] [Related]
19. Cell cycle protein cyclin Y is associated with human non-small-cell lung cancer proliferation and tumorigenesis.
Yue W; Zhao X; Zhang L; Xu S; Liu Z; Ma L; Jia W; Qian Z; Zhang C; Wang Y; Yang X
Clin Lung Cancer; 2011 Jan; 12(1):43-50. PubMed ID: 21273179
[TBL] [Abstract][Full Text] [Related]
20. Mammalian Eps15 homology domain 1 potentiates angiogenesis of non-small cell lung cancer by regulating β2AR signaling.
Wang T; Xing Y; Meng Q; Lu H; Liu W; Yan S; Song Y; Xu X; Huang J; Cui Y; Jia D; Cai L
J Exp Clin Cancer Res; 2019 Apr; 38(1):174. PubMed ID: 31023336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]